Recent Finacing
Recent Raise
Tubulis develops proprietary antibody-drug conjugates (ADCs) that aim to deliver durable, targeted anti-tumor activity in difficult-to-treat solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Tubulis.
